Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06142357
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2023-11-16
Brief Title:
Secukinumab Drug Survival Effectiveness and Tolerability in Pediatric Patients With Psoriasis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis